Literature DB >> 10226062

Transforming growth factor-alpha deficiency reduces pulmonary fibrosis in transgenic mice.

D K Madtes1, A L Elston, R C Hackman, A R Dunn, J G Clark.   

Abstract

Despite evidence that implicates transforming growth factor-alpha (TGF-alpha) in the pathogenesis of acute lung injury, the contribution of TGF-alpha to the fibroproliferative response is unknown. To determine whether the development of pulmonary fibrosis depends on TGF-alpha, we induced lung injury with bleomycin in TGF-alpha null-mutation transgenic mice and wild-type mice. Lung hydroxyproline content was 1.3, 1.2, and 1.6 times greater in wild-genotype mice than in TGF-alpha-deficient animals at Days 10, 21, and 28, respectively, after a single intratracheal injection of bleomycin. At Days 7 and 10 after bleomycin treatment, lung total RNA content was 1.5 times greater in wild-genotype mice than in TGF-alpha-deficient animals. There was no significant difference between mice of the two genotypes in lung total DNA content or nuclear labeling indices after bleomycin administration. Wild-genotype mice had significantly higher lung fibrosis scores at Days 7 and 14 after bleomycin treatment than did TGF-alpha-deficient animals. There was no significant difference between TGF-alpha-deficient mice and wild-genotype mice in lung inflammation scores after bleomycin administration. To determine whether expression of other members of the epidermal growth factor (EGF) family is increased after bleomycin-induced injury, we measured lung EGF and heparin-binding- epidermal growth factor (HB-EGF) mRNA levels. Steady-state HB-EGF mRNA levels were 321% and 478% of control values in bleomycin-treated lungs at Days 7 and 10, respectively, but were not significantly different in TGF-alpha-deficient and in wild-genotype mice. EGF mRNA was not detected in normal or bleomycin-treated lungs of mice of either genotype. These results show that TGF-alpha contributes significantly to the pathogenesis of pulmonary fibrosis after bleomycin-induced injury, and that compensatory increases in other EGF family members do not occur in TGF-alpha-deficient mice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226062     DOI: 10.1165/ajrcmb.20.5.3526

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  32 in total

1.  Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin.

Authors:  T Betsuyaku; Y Fukuda; W C Parks; J M Shipley; R M Senior
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Overactive Epidermal Growth Factor Receptor Signaling Leads to Increased Fibrosis after Severe Acute Respiratory Syndrome Coronavirus Infection.

Authors:  Thiagarajan Venkataraman; Christopher M Coleman; Matthew B Frieman
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

3.  In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis.

Authors:  Simona Inghilleri; Patrizia Morbini; Tiberio Oggionni; Sergio Barni; Carla Fenoglio
Journal:  Histochem Cell Biol       Date:  2005-11-24       Impact factor: 4.304

4.  Inhibition of the αvβ6 integrin leads to limited alteration of TGF-α-induced pulmonary fibrosis.

Authors:  Satish K Madala; Thomas R Korfhagen; Stephanie Schmidt; Cynthia Davidson; Ramakrishna Edukulla; Machiko Ikegami; Shelia M Violette; Paul H Weinreb; Dean Sheppard; William D Hardie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-02-07       Impact factor: 5.464

5.  Transforming growth factor alpha is a critical mediator of radiation lung injury.

Authors:  Eun Joo Chung; Kathryn Hudak; Jason A Horton; Ayla White; Bradley T Scroggins; Shiva Vaswani; Deborah Citrin
Journal:  Radiat Res       Date:  2014-08-12       Impact factor: 2.841

6.  Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.

Authors:  Raghad Nemo; Noel Murcia; Katherine Macrae Dell
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

Review 7.  Animal models for the study of liver fibrosis: new insights from knockout mouse models.

Authors:  Hiromitsu Hayashi; Takao Sakai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-02-24       Impact factor: 4.052

8.  Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

Authors:  Carl T D'Angio; William M Maniscalco
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

9.  Early growth response-1 suppresses epidermal growth factor receptor-mediated airway hyperresponsiveness and lung remodeling in mice.

Authors:  Elizabeth L Kramer; Elizabeth M Mushaben; Patricia A Pastura; Thomas H Acciani; Gail H Deutsch; Gurjit K Khurana Hershey; Thomas R Korfhagen; William D Hardie; Jeffrey A Whitsett; Timothy D Le Cras
Journal:  Am J Respir Cell Mol Biol       Date:  2009-02-02       Impact factor: 6.914

10.  Mesenchymal cell survival in airway and interstitial pulmonary fibrosis.

Authors:  James C Bonner
Journal:  Fibrogenesis Tissue Repair       Date:  2010-08-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.